 BOULDER, Colo.--BUSINESS WIRE--Clovis Oncology, Inc. NASDAQ:CLVS announced today that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission SEC to renew its previously established ATM facility under which it may offer and sell, from time to time, additional shares of its common stock having an aggregate offering price of up to 125,000,000 through an at-the-market equity offering program the ATM Program. The timing and amount of any sales will be de 